Yuan Yuan1,2, Bo Zhou1,2, Shunan Wang1,2, Jia Ma3, Fen Dong4, Min Yang1,2, Zhixin Zhang2, Wenquan Niu4. 1. Graduate School, Beijing University of Chinese Medicine, Beijing, China. 2. International Medical Services, China-Japan Friendship Hospital, Beijing, China. 3. Department of Pediatrics, Oriental Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China. 4. Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
Abstract
Objectives: Based on data from the China National Health Survey, we aimed to examine the association between body height and cardiometabolic disease (CMD) in a large adult population from Shaanxi province, and further to test whether this association was hinged upon other population characteristics. Methods: This population-based study was conducted in 2014 in Shaanxi Province, China. Utilizing a multi-stage stratified cluster sampling method, total 5,905 adults with complete data were eligible for analysis, and 1,151 (19.5%) of them had CMD. Of 1,151 CMD patients, 895 (15.1%) had one disorder and 256 (4.4%) had ≥2 disorders. Results: Using the bi-directional stepwise method and all-subsets regression, five factors-age, body mass index, family histories of CMD, exercise, and height-constituted the optimal model when predicting CMD risk. Restricted cubic spline regression showed a reduced tendency towards CMD with the increase of body height, with per 10 cm increment in body height corresponding to 14% reduced risk. Ordinal Logistic regression supported the contribution of body height on both continuous and categorical scales to CMD risk before and after adjustment, yet this contribution was significantly confounded by exercise and education, especially by exercise, which can explain 65.4% of total impact. For example, short stature was associated with an increased risk of CMD after multivariable adjustment not including exercise and education (odds ratio, 95% confidence interval, P: 1.42, 1.21 to 1.66, <0.001), and tall stature was associated with a reduced risk (0.77, 0.64 to 0.92, 0.003). Conclusions: Our findings indicate short stature was a risk factor, yet tall stature was a protective factor for CMD in Chinese. Notably, the prediction of short and tall stature for CMD may be mediate in part by exercise.
Objectives: Based on data from the China National Health Survey, we aimed to examine the association between body height and cardiometabolic disease (CMD) in a large adult population from Shaanxi province, and further to test whether this association was hinged upon other population characteristics. Methods: This population-based study was conducted in 2014 in Shaanxi Province, China. Utilizing a multi-stage stratified cluster sampling method, total 5,905 adults with complete data were eligible for analysis, and 1,151 (19.5%) of them had CMD. Of 1,151 CMDpatients, 895 (15.1%) had one disorder and 256 (4.4%) had ≥2 disorders. Results: Using the bi-directional stepwise method and all-subsets regression, five factors-age, body mass index, family histories of CMD, exercise, and height-constituted the optimal model when predicting CMD risk. Restricted cubic spline regression showed a reduced tendency towards CMD with the increase of body height, with per 10 cm increment in body height corresponding to 14% reduced risk. Ordinal Logistic regression supported the contribution of body height on both continuous and categorical scales to CMD risk before and after adjustment, yet this contribution was significantly confounded by exercise and education, especially by exercise, which can explain 65.4% of total impact. For example, short stature was associated with an increased risk of CMD after multivariable adjustment not including exercise and education (odds ratio, 95% confidence interval, P: 1.42, 1.21 to 1.66, <0.001), and tall stature was associated with a reduced risk (0.77, 0.64 to 0.92, 0.003). Conclusions: Our findings indicate short stature was a risk factor, yet tall stature was a protective factor for CMD in Chinese. Notably, the prediction of short and tall stature for CMD may be mediate in part by exercise.
Authors: Martin Horan; Vicky Newsway; Mark D Lewis; Tammy E Easter; D Aled Rees; Arti Mahto; David S Millar; Annie M Procter; Maurice F Scanlon; Ian B Wilkinson; Ian P Hall; Amanda Wheatley; John Blakey; Philip M W Bath; John R Cockcroft; Michael Krawczak; David N Cooper Journal: Hum Genet Date: 2006-03-30 Impact factor: 4.132
Authors: Eveline Nüesch; Caroline Dale; Tom M Palmer; Jon White; Brendan J Keating; Erik Pa van Iperen; Anuj Goel; Sandosh Padmanabhan; Folkert W Asselbergs; W M Verschuren; C Wijmenga; Y T Van der Schouw; N C Onland-Moret; Leslie A Lange; G K Hovingh; Suthesh Sivapalaratnam; Richard W Morris; Peter H Whincup; Goya S Wannamethe; Tom R Gaunt; Shah Ebrahim; Laura Steel; Nikhil Nair; Alexander P Reiner; Charles Kooperberg; James F Wilson; Jennifer L Bolton; Stela McLachlan; Jacqueline F Price; Mark Wj Strachan; Christine M Robertson; Marcus E Kleber; Graciela Delgado; Winfried März; Olle Melander; Anna F Dominiczak; Martin Farrall; Hugh Watkins; Maarten Leusink; Anke H Maitland-van der Zee; Mark Ch de Groot; Frank Dudbridge; Aroon Hingorani; Yoav Ben-Shlomo; Debbie A Lawlor; A Amuzu; M Caufield; A Cavadino; J Cooper; T L Davies; F Drenos; J Engmann; C Finan; C Giambartolomei; R Hardy; S E Humphries; E Hypponen; M Kivimaki; D Kuh; M Kumari; K Ong; V Plagnol; C Power; M Richards; S Shah; T Shah; R Sofat; P J Talmud; N Wareham; H Warren; J C Whittaker; A Wong; D Zabaneh; George Davey Smith; Jonathan C Wells; David A Leon; Michael V Holmes; Juan P Casas Journal: Int J Epidemiol Date: 2016-12-01 Impact factor: 7.196
Authors: Brianna Bourgeois; Krista Watts; Diana M Thomas; Owen Carmichael; Frank B Hu; Moonseong Heo; John E Hall; Steven B Heymsfield Journal: Medicine (Baltimore) Date: 2017-12 Impact factor: 1.817